Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call
Rhea-AI Summary
Cibus (Nasdaq: CBUS) will report fourth quarter 2025 financial results on Tuesday, March 17, 2026 after the market close. Management will host a conference call and audio webcast at 4:30 p.m. ET to discuss results and company updates.
Dial-in numbers, conference ID, replay details, and a live webcast with slides will be available on the company's Investor Events page; an archived webcast will remain available for 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – CBUS
In the Mar 4 session, CBUS declined 5.67%, reflecting a notable negative market reaction. Argus tracked a trough of -7.7% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 06 | UK partnership project | Positive | -7.1% | Joined UK-funded precision breeding project targeting Light Leaf Spot resistance. |
| Jan 29 | Offering priced | Negative | +9.1% | Priced $20M underwritten stock offering at $1.50 per share. |
| Jan 28 | Offering proposed | Negative | +9.1% | Announced proposed underwritten stock offering under effective Form S-3. |
| Jan 05 | Rice LOI signed | Positive | +7.5% | Non-binding LOI with Interoc to commercialize HT rice traits in Latin America. |
| Dec 11 | EU regulatory update | Positive | +4.8% | Welcomed positive EU NGT legislation outcome supporting gene-edited plants. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has produced mixed reactions: positive strategic and partnership updates at times saw aligned gains, while financings and a UK partnership led to divergent price moves.
Over the past several months, Cibus has balanced strategic progress with financing needs. A December 2025 update on supportive EU NGT legislation and a January 2026 LOI with Interoc on herbicide‑tolerant rice traits both coincided with positive price reactions. In contrast, a February 2026 UK precision breeding partnership saw a negative move. Two January 2026 offering announcements generated gains despite dilution concerns. Today’s earnings date and call notice fits into an active period of capital raises and commercialization initiatives.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report fourth quarter 2025 financial results on Tuesday, March 17, 2026. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.
Title: Cibus, Inc. Fourth Quarter 2025 Results Conference Call
Event Date: Tuesday, March 17, 2026
Time: 4:30 p.m. ET
Participant Numbers: +1-800-343-5172 (U.S.), +1-203-518-9856 (International)
The conference ID “CIBUS” or 24287 will be required for entry
Event Link: https://investor.cibus.com/events
For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Tuesday, March 31, 2026, and can be accessed by dialing +1-844-512-2921 (U.S.), +1-412-317-6671 (International) and entering replay passcode: 11160915.
A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.
About Cibus
Cibus is a leader in developing traits (characteristics) that address critical productivity, yield and sustainability challenges. Cibus’ proprietary high-throughput gene-editing technologies drive its long-term focus on productivity traits for farmers for the major global row crops. Cibus is not a seed company. It is a technology company that uses its gene editing technologies to develop plant traits at a fraction of the time and cost of conventional breeding and to license them to customers in exchange for royalties, leveraging its strong partnerships across the seed industry as a whole.
Cibus Contacts:
Investor Relations
Jeff Sonnek – ICR
jeff.sonnek@icrinc.com
Media Relations
Colin Sanford
colin@bioscribe.com
203-918-4347
